Silencing of KCNQ1OT1 Decreases Oxidative Stress and Pyroptosis of Renal Tubular Epithelial Cells

References

• Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–906. doi:10.1056/NEJMc1602469
   PubMed Web of Science ®Google Scholar
• Jian W, Jibo L, Yaqin D, et al. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy. Biochem Biophys Res Commun. 2018;503(2):977–983. S0006291X18314177.
   PubMedGoogle Scholar
• IDF. IDF global overview of diabetes. Chin Cent Pract. 2014;17(26):3124.
   Google Scholar
• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228. doi:10.1038/nrendo.2011.183
   PubMed Web of Science ®Google Scholar
• Aboudehen K, Farahani S, Kanchwala M, et al. Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling. J Biol Chem. 2018;293(24):jbc.RA118.001723. doi:10.1074/jbc.RA118.001723
   PubMed Web of Science ®Google Scholar
• Skroblin P, Mayr M. “Going Long”: long non-coding RNAs as biomarkers. Circ Res. 2014;115(7):607–609. doi:10.1161/CIRCRESAHA.114.304839
   PubMedGoogle Scholar
• Sheng S-R, Wu J-S, Tang Y-L, Liang X-H. Long noncoding RNAs: emerging regulators of tumor angiogenesis. Future Oncol. 2017;13(17):1551–1562. fon-2017-0149.
   PubMedGoogle Scholar
• Liu B, Sun L, Liu Q, et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015;27(3):370–381. doi:10.1016/j.ccell.2015.02.004
   PubMed Web of Science ®Google Scholar
• Viereck J, Thum T. Circulating noncoding RNAs as Biomarkers of cardiovascular disease and injury. Circ Res. 2017;120(2):381–399. doi:10.1161/CIRCRESAHA.116.308434
   PubMedGoogle Scholar
• Thum T, Condorelli G. Long noncoding RNAs and MicroRNAs in cardiovascular pathophysiology. Circ Res. 2015;116(4):751–762. doi:10.1161/CIRCRESAHA.116.303549
   PubMed Web of Science ®Google Scholar
• Arvaniti E, Moulos P, Vakrakou A, et al. Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases. Sci Rep. 2016;6:26235. doi:10.1038/srep26235
   PubMedGoogle Scholar
• Zhou P, Chen Z, Zou Y, Wan X. Roles of non-coding RNAs in acute kidney injury. Kidney Blood Press Res. 2016;41(6):757. doi:10.1159/000450566
   PubMed Web of Science ®Google Scholar
• Wang YZ, Zhu DY, Xie XM, et al. EA15, MIR22, LINC00472 as diagnostic markers for diabetic kidney disease. J Cell Physiol. 2019;234(6):8797–8803. doi:10.1002/jcp.27539
   PubMedGoogle Scholar
• Jiao HY, Xie DL, Qiao YH. LncRNA PRINS is involved in the development of nephropathy in patients with diabetes via interaction with Smad7. Exp Ther Med. 2019;17(4):3203–3208. doi:10.3892/etm.2019.7307
   PubMed Web of Science ®Google Scholar
• Yang F, Qin Y, Wang Y, et al. LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy. Cell Physiol Biochem. 2018;50(4):1230–1244. doi:10.1159/000494576
   PubMedGoogle Scholar
• Travers ME, Mackay DJ, Dekker Nitert M, et al. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes. 2013;62(3):987–992
   PubMed Web of Science ®Google Scholar
• Yu Q, Lu Z, Tao L, et al. ROS-dependent neuroprotective effects of nahs in ischemia brain injury involves the PARP/AIF pathway. Cell Physiol Biochem. 2015;36(4):1539–1551. doi:10.1159/000430317
   PubMedGoogle Scholar
• Dong Z, Yang P, Qiu X, et al. KCNQ1OT1 facilitates progression of non-small-cell lung carcinoma via modulating miRNA-27b-3p/HSP90AA1 axis. J Cell Physiol. 2019;234(7):11304–11314. doi:10.1002/jcp.v234.7
   PubMed Web of Science ®Google Scholar
• Rask-Madsen C, GL K. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20–33. doi:10.1016/j.cmet.2012.11.012
   PubMed Web of Science ®Google Scholar
• Fineberg D, Jandeleit-Dahm KAM, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013;9(12):713–723. doi:10.1038/nrendo.2013.184
   PubMed Web of Science ®Google Scholar
• Guo J, Liu ZS, Gong RJ. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease. Clin Sci. 2019;133(12):1321–1339. doi:10.1042/CS20190372
   PubMed Web of Science ®Google Scholar
• Hao LJ, Li Q, Zhao X, Li YL, Zhang C. A long noncoding RNA LOC103690121 promotes hippocampus neuronal apoptosis in streptozotocin-induced type 1 diabetes. Neurosci Lett. 2019;703:11–18. doi:10.1016/j.neulet.2019.03.006
   PubMed Web of Science ®Google Scholar
• Chen YW, Zhang ZF, Zhu DQ, Zhao WC, Li F. Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition. Biosci Rep. 2019;39:8. doi:10.1042/BSR20190444
   Google Scholar
• Huo W, Hou Y, Li Y, Li H. Downregulated lncRNA-MIAT confers protection against erectile dysfunction by downregulating lipoprotein lipase via activation of miR328a-5p in diabetic rats. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1226–1240. doi:10.1016/j.bbadis.2019.01.018
   PubMedGoogle Scholar
• Asahara SI, Etoh H, Inoue H, Teruyama K, Kido Y. Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c. Proc Natl Acad Sci U S A. 2015;112(27):8332–8337. doi:10.1073/pnas.1422104112
   PubMedGoogle Scholar
• Yin M, Ren X, Zhang X, et al. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene. 2015;34(6):691–703. doi:10.1038/onc.2013.597
   PubMedGoogle Scholar
• Zhang XZ, Liu FY, Wang QQ, Geng YX. Overexpressed microRNA-506 and microRNA-124 alleviate H2O2-induced human cardiomyocyte dysfunction by targeting kruppel-like factor 4/5. Mol Med Rep. 2017;16(4):5363–5369. doi:10.3892/mmr.2017.7243
   PubMedGoogle Scholar
• Miao EA, Leaf IA, Treuting PM, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010;11(12):1136–1142. doi:10.1038/ni.1960
   PubMed Web of Science ®Google Scholar
• Jorgensen I, Zhang Y, Krantz BA, Miao EA. Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis. J Exp Med. 2016;213(10):2113–2128. doi:10.1084/jem.20151613
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signaling. Nature. 2015;526(7575):666–671.
   PubMed Web of Science ®Google Scholar
• Jourdan T, Godlewski G, Cinar R, et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med. 2013;19(9):1132–1140.
   PubMedGoogle Scholar
• Li X, Zeng L, Cao C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327–335. doi:10.1016/j.yexcr.2016.12.006
   PubMed Web of Science ®Google Scholar
• Ding J, Wang K, Liu W, et al. Erratum: pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;540(7631):150
   PubMed Web of Science ®Google Scholar